Jump to Navigation

Facebook Connect

User login

National Lipid Association Names New Officers

Experts in the field of clinical lipidology elected as officers of medical society

focused on treating cardiometabolic disorders


(JACKSONVILLE, FLA.)—The National Lipid Association (NLA) recently elected new officers to serve a one-year term on its Board of Directors. The election came just prior to the organization’s Annual Scientific Sessions held May 1–4 in Orlando, Fla. The NLA is a nonprofit, multidisciplinary medical society that represents more than 3,000 members in the U.S. and provides continuing medical education for physicians and other health care professionals who practice in the field of clinical lipidology.

Terry A. Jacobson, MD, FNLA was elected president of the NLA. Dr. Jacobson is a leading expert in hyperlipidemia, nutrition, and drug management of hypercholesterolemia, coronary heart disease risk reduction strategies, and clinical practice implementation. He currently serves as professor of medicine at Emory University and director of the Office of Health Promotion and Disease Prevention at Grady Health Systems, both in Atlanta.
Carl E. Orringer, MD, FNLA, was elected president-elect of the NLA. Dr. Orringer recently served as the director of the Preventive Cardiovascular Medicine program, the lipid clinic, and the LDL apheresis program at the University Hospitals Case Medical Center Harrington Heart and Vascular Institute. In May 2014 Dr. Orringer joined the faculty of the Cardiology Division at the University of Miami Medical Center where he is an associate professor of medicine and director of the Preventive Cardiovascular Medicine and LDL apheresis program.

Robert A. Wild, MD, MPH, PhD, FNLA, was elected treasurer of the NLA. As professor of obstetrics/gynecology, clinical epidemiology, and preventive medicine, Dr. Wild currently teaches evidenced-based health care practice at Oklahoma University Health Sciences Center. He maintains a private practice focusing on cardiometabolic disorders, runs the Reproductive Endocrine Clinic, and is chief of gynecology at the VA Medical Center in Oklahoma City.

Joyce L. Ross, MSN, CRNP, FNLA, was elected secretary of the NLA. Ross is a certified registered nurse practitioner and clinical lipid specialist with concentrated training in preventive cardiology. Her clinical affiliation is with the University of Pennsylvania as well as an independent clinical consultant on cardiovascular risk intervention and education. She has been active in clinical research and has been both a clinical coordinator and sub-investigator on several cardiovascular risk reduction trials for lipids, and other aspects of risk reduction.

In addition, new presidents were elected for each of the five regional chapters of the NLA.

They are:
Pacific Lipid Association: Paul D. Rosenblit, MD, PhD, FACE, FNLA; clinical professor of medicine at the University of California and the director of the Diabetes Out-patient Clinic at UCI Medical Center.
Southeast Lipid Association: Lori A. Alexander, MSHS, RD, CCRC, FNLA; site director for St. Johns Center for Clinical Research in Ponte Vedra Beach, Fla.
Midwest Lipid Association: Kaye-Eileen Willard, MD, FNLA; chief of medicine at Wheaton Franciscan Healthcare All Saints in Racine, Wis.
Southwest Lipid Association: Krishnaswami Vijayaraghavan (Kris Vijay), MD, MS, FACC, FACP, FCCP, FNLA, MSHS; vice president at Scottsdale Cardiovascular Center.
Northeast Lipid Association: Joyce L. Ross, MSN, CRNP, FNLA; independent clinical consultant on cardiovascular risk intervention and education.

The NLA is focused on enhancing the practice of lipid management in clinical medicine, with a membership comprised of physicians, physician assistants, dietitians, nurses, pharmacists, researchers, and other health care professionals. Lipid management involves the treatment of disruptions in the amount of lipids in the blood (dyslipidemia). The NLA’s thousands of members share a common goal: to enhance the practice of lipid management in clinical medicine and to reduce the morbidity and mortality associated with atherosclerotic disease.

No votes yet
Publish Date: 
May 21, 2014 - 12:00pm

by Dr. Radut.